Biotechnology Stocks
| # | Last 7 Days | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1138 |  SRRK Scholar Rock Holding Corporation - Common Stock | 56.07 USD | -0.76% | +7.60% | +15.30% | +86.78% | 6.83 B USD | ||
| 1185 |  COGT Cogent Biosciences, Inc. - Common Stock | 36.28 USD | -1.23% | -4.12% | -9.41% | +131.53% | 6.30 B USD | ||
| 1192 |  BLTE Belite Bio Inc - American Depositary Shares | 159.15 USD | -1.19% | -2.26% | +3.12% | +145.60% | 6.26 B USD | ||
| 1199 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 95.71 USD | -0.62% | -4.45% | -16.88% | +36.48% | 6.21 B USD | ||
| 1206 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 109.70 USD | -1.26% | -4.88% | +5.64% | +351.44% | 6.14 B USD | ||
| 1207 |  TVTX Travere Therapeutics, Inc. - Common Stock | 64.15 USD | -2.37% | +2.53% | +10.70% | +122.98% | 6.05 B USD | ||
| 1210 |  ERAS Erasca, Inc. - Common Stock | 17.17 USD | -2.61% | -6.53% | -11.77% | +986.71% | 6.01 B USD | ||
| 1212 |  LQDA Liquidia Corporation - Common Stock | 68.57 USD | -0.07% | -9.43% | -20.44% | +203.41% | 6.14 B USD | ||
| 1230 |  DFTX Definium Therapeutics, Inc. - Common Shares | 42.45 USD | -5.48% | -3.63% | -2.75% | +180.94% | 5.70 B USD | ||
| 1240 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 60.35 USD | -0.69% | -2.05% | -7.93% | +47.95% | 5.84 B USD | ||
| 1251 |  PTCT PTC Therapeutics, Inc. - Common Stock | 68.20 USD | -2.32% | -4.89% | -12.14% | +34.68% | 5.69 B USD | ||
| 1260 |  CRSP CRISPR Therapeutics AG - Common Shares | 57.20 USD | -3.87% | +7.42% | +20.02% | +5.44% | 5.53 B USD | ||
| 1266 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 281.87 USD | -1.54% | -4.59% | -7.57% | +50.64% | 5.62 B USD | ||
| 1344 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 29.26 USD | -0.81% | +2.49% | +16.07% | +14.03% | 5.04 B USD | ||
| 1372 |  DYN Dyne Therapeutics, Inc. - Common Stock | 25.38 USD | -2.76% | -0.47% | +1.52% | +8.42% | 4.74 B USD | ||
| 1382 |  EWTX Edgewise Therapeutics, Inc. - Common Stock | 43.20 USD | -2.22% | -0.32% | +3.85% | +183.65% | 4.69 B USD | ||
| 1418 |  CELC Celcuity Inc. - Common Stock | 91.32 USD | -2.36% | -0.72% | +8.57% | +72.56% | 4.47 B USD | ||
| 1449 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 59.68 USD | -0.23% | +1.96% | +10.97% | +188.87% | 4.37 B USD | ||
| 1468 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 39.27 USD | +1.58% | +77.61% | +112.27% | +323.17% | 4.38 B USD | ||
| 1477 |  RLAY Relay Therapeutics, Inc. - Common Stock | 18.88 USD | -2.88% | -5.93% | +2.22% | +411.65% | 4.14 B USD |
News Biotechnology Stocks
Crude Oil Down 3%; XPeng Shares Fall After Q2 Results - XPeng (NYSE:XPEV), Expion360 (NASDAQ:XPON)
Here's Why Acrivon Therapeutics, Inc. (ACRV) is a Great Momentum Stock to Buy
Moleculin Biotech (MBRX) Upgraded to Buy: Here's Why
This Darden Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday - Darden Restaurants (NYSE:DRI), Ja
GSK's sBLA for Jemperli Gets FDA Priority Tag in Rectal Cancer
Is SYRE a Buy Now as Clinical Catalysts Clash With Valuation Risk?
Can Spyre's SPY772 HS Study Broaden Its Growth Story Beyond Core IBD?
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |